Information:
Fel:
ID
14347
Beskrivning
Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102); ODM derived from: https://clinicaltrials.gov/show/NCT00404547
Länk
https://clinicaltrials.gov/show/NCT00404547
Nyckelord
Versioner (1)
- 2016-04-11 2016-04-11 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
11 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Asthma NCT00404547
Eligibility Asthma NCT00404547
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00404547
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
age and asthma
Item
18 years or older with diagnosis of asthma for at least 6 months
boolean
C0001779 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
C0004096 (UMLS CUI [2])
stable asthma
Item
clinically stable asthma at the time of study enrollment
boolean
C0004096 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,2])
ics
Item
clinical requirements for treatment with ics as outlined in the canadian asthma consensus guidelines
boolean
C3248292 (UMLS CUI [1])
ics stable dose
Item
if patients are currently on ics, the dose must be stable for 3 months and they must be willing to switch
boolean
C3248292 (UMLS CUI [1])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
exclusion criteria
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
ics and long acting beta-2-agonist
Item
on combination therapy (ics + long acting beta-2-agonist) for asthma in the past 3 months or require combination therapy
boolean
C3248292 (UMLS CUI [1,1])
C1373132 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C1373132 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
severe asthma
Item
severe asthma, one or more asthma exacerbations in the last 3 months requiring hospitalization or emergency room visit, or patients who have used systemic steroids more than 3 times in the past 6 months or who are currently using systemic steroids
boolean
C0581126 (UMLS CUI [1])
C0349790 (UMLS CUI [2])
C1527398 (UMLS CUI [3])
C0019993 (UMLS CUI [4])
C2825233 (UMLS CUI [5])
C0349790 (UMLS CUI [2])
C1527398 (UMLS CUI [3])
C0019993 (UMLS CUI [4])
C2825233 (UMLS CUI [5])
mild asthma requiring short acting beta-2-agonists only
Item
mild asthma requiring short acting beta-2-agonists only
boolean
C0581124 (UMLS CUI [1,1])
C2936789 (UMLS CUI [1,2])
C2936789 (UMLS CUI [1,2])
contraindication to ics therapy
Item
patients with a contraindication to ics therapy
boolean
C1301624 (UMLS CUI [1,1])
C3248292 (UMLS CUI [1,2])
C3248292 (UMLS CUI [1,2])
comorbidity limiting study protocol
Item
any other disease or medical condition requiring further clinical evaluation, which in the opinion of the primary care practitioner may interfere with the clinical study or interfere with the diagnosis of asthma.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
pregnancy, breast feeding, intention to become pregnant during the course of the study or lack of safe contraception in pre-menopausal women
Item
pregnancy, breast feeding, intention to become pregnant during the course of the study or lack of safe contraception in pre-menopausal women
boolean
C0032961 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0032961 (UMLS CUI [4,1])
C1283828 (UMLS CUI [4,2])
C0700589 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0032961 (UMLS CUI [4,1])
C1283828 (UMLS CUI [4,2])